tiprankstipranks
Advertisement

VNGLF - ETF AI Analysis

Compare

Top Page

VNGLF

Vanguard FTSE Developed Europe UCITS ETF Accum EUR (VNGLF)

Rating:60Neutral
Price Target:
VNGLF, the Vanguard FTSE Developed Europe UCITS ETF, has a solid overall rating driven by high-quality European blue chips like Novartis, HSBC, and AstraZeneca, which show strong financial performance, positive earnings outlooks, and generally supportive technical trends. Additional support comes from stable, well-established names such as Nestlé, Shell, Siemens, and Roche, though some holdings like SAP and Shell face issues such as weaker technical momentum, valuation concerns, and cash flow or regional risks that slightly weigh on the fund. The main risk factor is its concentration in developed European markets, which exposes investors to region-specific economic and regulatory challenges.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and over the past month, indicating positive recent momentum.
Low Expense Ratio
The fund charges a very low fee, which helps investors keep more of their returns over time.
Broad European Diversification
Holdings spread across major European markets like the UK, Germany, France, and Switzerland help reduce the impact of weakness in any single country.
Negative Factors
Mixed Performance Among Top Holdings
While several leading positions have performed strongly, a few large holdings have been weak, which can drag on overall returns.
Heavy Tilt Toward Europe
The ETF is focused mainly on developed European markets, so it may lag if other regions, such as the U.S. or emerging markets, perform better.
Limited Technology Exposure
The fund has only a small allocation to the technology sector, which could mean missing out if tech stocks continue to lead global markets.

VNGLF vs. SPDR S&P 500 ETF (SPY)

VNGLF Summary

This ETF, the Vanguard FTSE Developed Europe UCITS ETF, aims to follow the FTSE Developed Europe Index, which covers a wide range of large, mid, and smaller companies from developed countries in Europe. It holds many well-known names such as Nestlé, Shell, and HSBC, giving you instant diversification across different sectors and countries like the UK, Germany, and France. Because it reinvests dividends, it can be attractive for long-term investors looking for growth and broad international exposure. A key risk is that its value can rise and fall with European stock markets and currency movements.
How much will it cost me?The Vanguard FTSE Developed Europe UCITS ETF (VNGLF) has an expense ratio of 0.1%, meaning you’ll pay $1 per year for every $1,000 invested. This is lower than average because the fund is passively managed, tracking the FTSE Developed Europe Index to keep costs down.
What would affect this ETF?Positive drivers for VNGLF include potential economic growth in developed European countries like Germany, France, and the UK, which could boost the performance of its top holdings in sectors such as financials, healthcare, and technology. However, negative factors such as rising interest rates or geopolitical tensions in Europe could impact market stability and weigh on the ETF's performance. Additionally, sector-specific challenges, like regulatory changes in healthcare or energy, could affect the fund's returns.

VNGLF Top 10 Holdings

This Vanguard Europe ETF leans heavily on a mix of healthcare, banks, and energy, with a clear tilt toward developed markets like the UK, Switzerland, Germany, France, and the Netherlands. ASML is one of the main engines, rising steadily and giving the fund a tech-powered boost. HSBC is another bright spot, with strong recent gains helping financials pull their weight. On the flip side, SAP has been dragging the fund, and Nestlé looks a bit tired, trading more sideways to soft. Energy names like Shell and TotalEnergies add a cyclical kick, with recently mixed but generally supportive momentum.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV3.68%$239.78M€498.49B113.07%
76
Outperform
AstraZeneca2.14%$139.17M$286.22B29.15%
80
Outperform
Novartis AG2.12%$138.37MCHF211.11B25.94%
80
Outperform
HSBC Holdings2.04%$132.58M£230.84B59.32%
80
Outperform
Roche Holding AG2.03%$131.92M$330.18B27.90%
73
Outperform
Shell (UK)1.98%$128.89M£179.32B32.21%
73
Outperform
Nestlé SA1.85%$120.37MCHF198.82B-4.90%
71
Outperform
Siemens1.28%$83.41M€204.52B27.59%
74
Outperform
SAP SE1.28%$83.38M€174.34B-42.22%
66
Neutral
TotalEnergies SE1.25%$81.09M€170.89B48.41%
78
Outperform

VNGLF Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
64.48
Positive
100DMA
64.87
Positive
200DMA
62.12
Positive
Market Momentum
MACD
0.46
Positive
RSI
54.67
Neutral
STOCH
70.44
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For VNGLF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 66.25, equal to the 50-day MA of 64.48, and equal to the 200-day MA of 62.12, indicating a bullish trend. The MACD of 0.46 indicates Positive momentum. The RSI at 54.67 is Neutral, neither overbought nor oversold. The STOCH value of 70.44 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for VNGLF.

VNGLF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$2.50B0.10%
60
Neutral
$9.25B0.50%
63
Neutral
$8.79B0.09%
64
Neutral
$8.56B0.09%
63
Neutral
$4.45B0.29%
68
Neutral
$1.77B0.58%
62
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
VNGLF
Vanguard FTSE Developed Europe UCITS ETF Accum EUR
66.50
12.36
22.83%
EZU
iShares MSCI Eurozone ETF
BBEU
JPMorgan BetaBuilders Europe ETF
IEUR
iShares Core MSCI Europe ETF
FEZ
SPDR EURO STOXX 50 ETF
HEDJ
WisdomTree Europe Hedged Equity Fund
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement